Impact of Race and Ethnicity on Use and Outcomes of Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

被引:4
作者
Patlolla, Sri Harsha [1 ]
Schaff, Hartzell V. [1 ]
Nishimura, Rick A. [2 ]
Eleid, Mackram F. [2 ]
Geske, Jeffrey B. [2 ]
Ommen, Steve R. [2 ]
机构
[1] Mayo Clin, Dept Cardiovasc Surg, 200 First Street SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2023年 / 12卷 / 01期
关键词
disparities; ethnicity; hypertrophic cardiomyopathy; race; septal reduction; MYECTOMY; ABLATION; VOLUME;
D O I
10.1161/JAHA.122.026661
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundInformation on impact of race and ethnicity on use and early outcomes of septal reduction therapies (SRTs) for obstructive hypertrophic obstructive cardiomyopathy are limited. Methods and ResultsUsing the National Inpatient Sample from January 2012 through December 2019, we identified all adult admissions with a primary diagnosis of obstructive hypertrophic cardiomyopathy and those undergoing SRT. Predictors of receiving SRT and outcomes including in-hospital mortality, complications, and resource use were evaluated in racial and ethnic groups. Among a total of 18 895 adult admissions with obstructive hypertrophic cardiomyopathy, SRT was performed in 7255 (38.4%) admissions. Septal myectomy was performed in 4930 (26.1%), while alcohol septal ablation was performed in 2325 (12.3%). In adjusted analysis, Black patient (versus White patient adjusted odds ratio, 0.65 [95% CI, 0.57-0.73]; P<0.001) and Hispanic patient admissions (versus White adjusted odds ratio, 0.78 [95% CI, 0.66-0.92]; P=0.003) were less likely to receive SRT. Among admissions undergoing SRT, in-hospital mortality was significantly higher for Hispanic (adjusted odds ratio, 3.38 [95% CI, 1.81-6.30], P<0.001) and other racial and ethnic groups (adjusted odds ratio 2.02 [95% CI, 1.00-4.11]; P=0.05) compared with White patient admissions, whereas Black patient admissions had comparable mortality. Black, Hispanic, and other ethnic group patients had higher rates of SRT complications and more frequent dismissals to acute care facilities. ConclusionsAmong obstructive hypertrophic cardiomyopathy hospitalizations, minoritized racial groups were less likely to receive SRT. Importantly, hospitalizations of Hispanic and other ethnic patients undergoing SRT had significantly higher in-hospital mortality and complication rates. Further studies with granular echocardiographic information to assess indications for SRT are needed to better understand these differences.
引用
收藏
页数:18
相关论文
共 20 条
  • [1] Disparities in the Diagnosis of Hypertrophic Obstructive Cardiomyopathy: A Narrative Review of Current Literature
    Burns, Joseph
    Jean-Pierre, Philippe
    [J]. CARDIOLOGY RESEARCH AND PRACTICE, 2018, 2018
  • [2] Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy
    Eberly, Lauren A.
    Day, Sharlene M.
    Ashley, Euan A.
    Jacoby, Daniel L.
    Jefferies, John Lynn
    Colan, Steven D.
    Rossano, Joseph W.
    Semsarian, Christopher
    Pereira, Alexandre C.
    Olivotto, Iacopo
    Ingles, Jodie
    Seidman, Christine E.
    Channaoui, Nadine
    Cirino, Allison L.
    Han, Larry
    Ho, Carolyn Y.
    Lakdawala, Neal K.
    [J]. JAMA CARDIOLOGY, 2020, 5 (01) : 83 - 91
  • [3] Women with hypertrophic cardiomyopathy have worse survival
    Geske, Jeffrey B.
    Ong, Kevin C.
    Siontis, Konstantinos C.
    Hebl, Virginia B.
    Ackerman, Michael J.
    Hodge, David O.
    Miller, Virginia M.
    Nishimura, Rick A.
    Oh, Jae K.
    Schaff, Hartzell V.
    Gersh, Bernard J.
    Ommen, Steve R.
    [J]. EUROPEAN HEART JOURNAL, 2017, 38 (46) : 3434 - U20
  • [4] Septal Myectomy in Hypertrophic Cardiomyopathy: National Outcomes of Concomitant Mitral Surgery
    Holst, Kimberly A.
    Hanson, Kristine T.
    Ommen, Steve R.
    Nishimura, Rick A.
    Habermann, Elizabeth B.
    Schaff, Hartzell V.
    [J]. MAYO CLINIC PROCEEDINGS, 2019, 94 (01) : 66 - 73
  • [5] INTRODUCTION TO THE HCUP NATIONAL INPATIENT SAMPLE (NIS), 2018, US
  • [6] With Great Power Comes Great Responsibility Big Data Research From the National Inpatient Sample
    Khera, Rohan
    Krumholz, Harlan M.
    [J]. CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2017, 10 (07):
  • [7] Hospital Volume Outcomes After Septal Myectomy and Alcohol Septal Ablation for Treatment of Obstructive Hypertrophic Cardiomyopathy US Nationwide Inpatient Database, 2003-2011
    Kim, Luke K.
    Swaminathan, Rajesh V.
    Looser, Patrick
    Minutello, Robert M.
    Wong, S. Chiu
    Bergman, Geoffrey
    Naidu, Srihari S.
    Gade, Christopher L. F.
    Charitakis, Konstantinos
    Singh, Harsimran S.
    Feldman, Dmitriy N.
    [J]. JAMA CARDIOLOGY, 2016, 1 (03) : 324 - 332
  • [8] Why we need more septal myectomy surgeons: An emerging recognition
    Maron, Barry J.
    Dearani, Joseph A.
    Maron, Martin S.
    Ommen, Steve R.
    Rastegar, Hassan
    Nishimura, Rick A.
    Swistel, Daniel G.
    Sherrid, Mark V.
    Ralph-Edwards, Anthony
    Rakowski, Harry
    Smedira, Nicholas G.
    Rowin, Ethan J.
    Desai, Milind Y.
    Lever, Harry M.
    Spirito, Paolo
    Ferrazzi, Paolo
    Schaff, Hartzell V.
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 154 (05) : 1681 - 1685
  • [9] Hypertrophic cardiomyopathy
    Maron, Barry J.
    Maron, Martin S.
    [J]. LANCET, 2013, 381 (9862) : 242 - 255
  • [10] Survival Differences in Women and Men After Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
    Meghji, Zahara
    Nguyen, Anita
    Fatima, Benish
    Geske, Jeffrey B.
    Nishimura, Rick A.
    Ommen, Steve R.
    Lahr, Brian D.
    Dearani, Joseph A.
    Schaff, Hartzell V.
    [J]. JAMA CARDIOLOGY, 2019, 4 (03) : 237 - 245